Heli Gao

1.2k total citations
55 papers, 825 citations indexed

About

Heli Gao is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Heli Gao has authored 55 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 34 papers in Epidemiology and 25 papers in Neurology. Recurrent topics in Heli Gao's work include Neuroendocrine Tumor Research Advances (33 papers), Lung Cancer Research Studies (27 papers) and Neuroblastoma Research and Treatments (25 papers). Heli Gao is often cited by papers focused on Neuroendocrine Tumor Research Advances (33 papers), Lung Cancer Research Studies (27 papers) and Neuroblastoma Research and Treatments (25 papers). Heli Gao collaborates with scholars based in China, United States and Germany. Heli Gao's co-authors include Xianjun Yu, Wenquan Wang, Liang Liu, Huaxiang Xu, Chuntao Wu, Wuhu Zhang, Quanxing Ni, Shirong Zhang, Shuaishuai Xu and Tianjiao Li and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Heli Gao

54 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heli Gao China 18 531 238 201 186 120 55 825
Louise Jackett Australia 12 556 1.0× 142 0.6× 176 0.9× 119 0.6× 72 0.6× 31 750
Maria Scardoni Italy 15 422 0.8× 266 1.1× 73 0.4× 176 0.9× 126 1.1× 21 824
Zoe Quandt United States 13 665 1.3× 187 0.8× 227 1.1× 145 0.8× 34 0.3× 36 967
Ilaria Maggio Italy 15 375 0.7× 225 0.9× 51 0.3× 114 0.6× 81 0.7× 30 716
Arata Tsutsumida Japan 18 635 1.2× 252 1.1× 170 0.8× 340 1.8× 67 0.6× 66 1.1k
Eckhard Fiedler Germany 18 332 0.6× 246 1.0× 108 0.5× 217 1.2× 77 0.6× 39 1.0k
Ying‐Ju Kuo Taiwan 15 361 0.7× 129 0.5× 90 0.4× 134 0.7× 68 0.6× 39 714
Davide Quaresmini Italy 11 352 0.7× 160 0.7× 51 0.3× 265 1.4× 257 2.1× 20 699
Hiroo Hata Japan 17 452 0.9× 140 0.6× 212 1.1× 185 1.0× 61 0.5× 62 875
Yi‐Ting Yen Taiwan 15 183 0.3× 73 0.3× 104 0.5× 178 1.0× 93 0.8× 80 760

Countries citing papers authored by Heli Gao

Since Specialization
Citations

This map shows the geographic impact of Heli Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heli Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heli Gao more than expected).

Fields of papers citing papers by Heli Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heli Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heli Gao. The network helps show where Heli Gao may publish in the future.

Co-authorship network of co-authors of Heli Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Heli Gao. A scholar is included among the top collaborators of Heli Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heli Gao. Heli Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wuhu, Dan Huang, Yi Qin, et al.. (2025). Small extracellular vesicle-miR-183-5p mediated crosstalk between tumor cells and macrophages in high-risk pancreatic neuroendocrine tumors. Oncogene. 44(32). 2907–2923. 2 indexed citations
2.
Zeng, Ye, Qiang Li, Wuhu Zhang, et al.. (2024). The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Cancer Letters. 588. 216769–216769. 9 indexed citations
3.
4.
Zhuo, Qifeng, Heli Gao, Yi Qin, et al.. (2023). MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression. Cancer Research. 83(13). 2226–2247. 20 indexed citations
5.
Wang, Fei, Yi Qin, Xin Lou, et al.. (2023). Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges. Endocrine. 80(2). 266–282. 5 indexed citations
6.
Gao, Heli, Wuhu Zhang, Huaxiang Xu, et al.. (2022). The optimal duration of capecitabine plus temozolomide in patients with well‐differentiated pancreatic NETs with or without maintenance therapy. Journal of Neuroendocrinology. 34(6). e13112–e13112. 1 indexed citations
7.
Xu, Xiaowu, Ye Zeng, Xin Lou, et al.. (2022). Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors. Pancreas. 51(10). 1404–1410. 3 indexed citations
8.
Lou, Xin, Heli Gao, Xiaowu Xu, et al.. (2022). The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors. Frontiers in Oncology. 12. 808448–808448. 7 indexed citations
9.
Ye, Long‐Yun, Kaizhou Jin, Zhiwen Xiao, et al.. (2022). Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer. EBioMedicine. 79. 104016–104016. 18 indexed citations
10.
Xu, Junfeng, Zheng Li, Qifeng Zhuo, et al.. (2022). Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway. Frontiers in Oncology. 12. 822039–822039. 7 indexed citations
11.
Gao, Heli, Wuhu Zhang, Huaxiang Xu, et al.. (2021). Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors. Endocrine Practice. 28(3). 292–297. 2 indexed citations
12.
Gao, Heli, et al.. (2020). Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1875(1). 188484–188484. 15 indexed citations
13.
Gao, Heli, Wenquan Wang, Xianjun Yu, & Liang Liu. (2020). Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma. Experimental Hematology and Oncology. 9(1). 28–28. 29 indexed citations
14.
Wang, Wenquan, et al.. (2019). The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1872(2). 188311–188311. 32 indexed citations
15.
Gao, Heli, Wenquan Wang, Huaxiang Xu, et al.. (2019). Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis. Pancreatology. 19(3). 472–477. 5 indexed citations
16.
Li, Tianjiao, Hao Li, Shuo Li, et al.. (2019). Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma. Cancer Medicine. 8(11). 5223–5231. 12 indexed citations
17.
Zhang, Shirong, Lie Yao, Wenquan Wang, et al.. (2018). Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 25(13). 3984–3993. 23 indexed citations
18.
Gao, Heli, Liang Liu, Zihao Qi, et al.. (2017). O-6-Methylguanine-DNA Methyltransferase and Response to Alkylation Agents in Neuroendocrine Tumor: A Meta-Analysis. JOP, journal of the pancreas. 18(3). 2 indexed citations
19.
Gao, Heli, Liang Liu, Wenquan Wang, et al.. (2017). Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor. Cancer Letters. 412. 188–193. 36 indexed citations
20.
Luo, Guopei, Kaizhou Jin, Cheng He, et al.. (2017). Revised nodal stage for pancreatic neuroendocrine tumors. Pancreatology. 17(4). 599–604. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026